gene_symbol
CD3E
hgnc_id
HGNC:1674
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Blinatumomab binds CD3ε on T cells to activate them and redirect killing toward CD19+ cells; T cells mediate perforin/granzyme cytotoxicity against CD19+ targets, not CD3+ cells.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Epsilon chain of the CD3/TCR complex on T cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06063317
disease_id_num_tar_ref
4123
drug_id_num_tar_ref
11130